Coronavirus disease 2019 and lung cancer: where are we?

Autor: Ocanto A; Department of Radiation Oncology, Hospital Universitario San Francisco de Asís, GenesiCare Madrid, 28002 Madrid, Spain.; Department of Radiation Oncology, Hospital Universitario Vithas La Milagrosa, GenesiCare Madrid, 28002 Madrid, Spain., Mielgo-Rubio X; Department of Medical Oncology, Hospital Universitario Fundación Alcorcón, 28922 Madrid, Spain., Luna Tirado J; Department of Radiation Oncology, Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain., Linares Mesa N; Department of Radiation Oncology, Hospital Universitario Juan Ramón Jiménez, 21005 Huelva, Spain., López Valcárcel M; Department of Radiation Oncology, Hospital Universitario Puerta de Hierro, 28222 Madrid, Spain., Pedraza S; Department of Radiation Oncology, Hospital Universitario 12 de Octubre Madrid, 28041 Madrid, Spain., Barragan VV; Department of Radiation Oncology, Hospital Universitario de Badajoz, 06080 Badajoz, Spain., Nieto PV; Department of Radiation Oncology, Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain., Martín JZ; Group of Translational Research in Cancer Immunotherapy, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga (UMA), Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain.; Department of Radiation Oncology, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain., Couñago F; Department of Radiation Oncology, Hospital Universitario San Francisco de Asís, GenesiCare Madrid, 28002 Madrid, Spain.; Department of Radiation Oncology, Hospital Universitario Vithas La Milagrosa, GenesiCare Madrid, 28002 Madrid, Spain.; Department of Radiation Oncology, Emilio Vargas, GenesisCare Madrid, 28002 Madrid, Spain.

Publikováno v: Exploration of targeted anti-tumor therapy [Explor Target Antitumor Ther] 2023; Vol. 4 (5), pp. 1082-1094. Date of Electronic Publication: 2023 Oct 30.